Related references
Note: Only part of the references are listed.First-in-Humans Imaging with 89Zr-Df-IAB22M2C Anti-CD8 Minibody in Patients with Solid Malignancies: Preliminary Pharmacokinetics, Biodistribution, and Lesion Targeting
Neeta Pandit-Taskar et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Radiomics Improves Cancer Screening and Early Detection
Robert J. Gillies et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Non-clinical tumor models reveal broad combination potential of ICOS agonist antibodies
Jeremy D. Waight et al.
CANCER RESEARCH (2020)
Immuno-PET Imaging to Assess Target Engagement: Experience from 89Zr-Anti-HER3 mAb (GSK2849330) in Patients with Solid Tumors
C. Willemien Menke-van der Houven van Oordt et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Imaging of Activated T Cells as an Early Predictor of Immune Response to Anti-PD-1 Therapy
Jelena Levi et al.
CANCER RESEARCH (2019)
The Effectiveness of Checkpoint Inhibitor Combinations and Administration Timing Can Be Measured by Granzyme B PET Imaging
Benjamin M. Larimer et al.
CLINICAL CANCER RESEARCH (2019)
CD8+ T-Cell Density Imaging with 64Cu-Labeled Cys-Diabody Informs Immunotherapy Protocols
Jai Woong Seo et al.
CLINICAL CANCER RESEARCH (2018)
Challenges and Promises of PET Radiomics
Gary J. R. Cook et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2018)
Imaging activated T cells predicts response to cancer vaccines
Israt S. Alam et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
CellProfiler 3.0: Next-generation image processing for biology
Claire McQuin et al.
PLOS BIOLOGY (2018)
1840PPreclinical evaluation of a non-depleting, first-in-class humanized IgG4 agonist anti-ICOS antibody
S Brett et al.
ANNALS OF ONCOLOGY (2018)
Tumor-immune profiling of murine syngeneic tumor models as a framework to guide mechanistic studies and predict therapy response in distinct tumor microenvironments
Jong W. Yu et al.
PLOS ONE (2018)
Fluorine-19 MRI for detection and quantification of immune cell therapy for cancer
Fanny Chapelin et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2018)
Tumor-draining lymph nodes are pivotal in PD-1/PD-L1 checkpoint therapy
Marieke F. Fransen et al.
JCI INSIGHT (2018)
Combination cancer immunotherapy targeting PD-1 and GITR can rescue CD8(+) T cell dysfunction and maintain memory phenotype
Bei Wang et al.
SCIENCE IMMUNOLOGY (2018)
Predicting the response to CTLA-4 blockade by longitudinal noninvasive monitoring of CD8 T cells
Mohammad Rashidian et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2017)
Non invasive imaging assessment of the biodistribution of GSK2849330, an ADCC and CDC optimized anti HER3 mAb, and its role in tumor macrophage recruitment in human tumor-bearing mice
Hasan Alsaid et al.
PLOS ONE (2017)
Delta-radiomics features for the prediction of patient outcomes in non-small cell lung cancer
Xenia Fave et al.
SCIENTIFIC REPORTS (2017)
Computational Radiomics System to Decode the Radiographic Phenotype
Joost J. M. van Griethuysen et al.
CANCER RESEARCH (2017)
A PET Imaging Strategy to Visualize Activated T Cells in Acute Graft-versus-Host Disease Elicited by Allogenic Hematopoietic Cell Transplant
John A. Ronald et al.
CANCER RESEARCH (2017)
Radiomics: Images Are More than Pictures, They Are Data
Robert J. Gillies et al.
RADIOLOGY (2016)
Immuno-PET of Murine T Cell Reconstitution Postadoptive Stem Cell Transplantation Using Anti-CD4 and Anti-CD8 Cys-Diabodies
Richard Tavare et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Engagement of the ICOS pathway markedly enhances efficacy of CTLA-4 blockade in cancer immunotherapy
Xiaozhou Fan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2014)
Highly multiplexed imaging of tumor tissues with subcellular resolution by mass cytometry
Charlotte Giesen et al.
NATURE METHODS (2014)
Engineered antibody fragments for immuno-PET imaging of endogenous CD8+ T cells in vivo
Richard Tavare et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Molecular Imaging in Tracking Tumor-Specific Cytotoxic T Lymphocytes (CTLs)
Zhiyi Liu et al.
THERANOSTICS (2014)
Long-term survival and immunological parameters in metastatic melanoma patients who responded to ipilimumab 10 mg/kg within an expanded access programme
Anna Maria Di Giacomo et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Convergent and divergent effects of costimulatory molecules in conventional and regulatory CD4+ T cells
Ei Wakamatsu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
CD8+ tumor-infiltrating lymphocytes predict favorable prognosis in malignant pleural mesothelioma after resection
Noriyuki Yamada et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial
Bradley C. Carthon et al.
CLINICAL CANCER RESEARCH (2010)
The Inducible Costimulator (ICOS) Is Critical for the Development of Human TH17 Cells
Chrystal M. Paulos et al.
SCIENCE TRANSLATIONAL MEDICINE (2010)
Predominant infiltration of macrophages and CD8+ T cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer
Osamu Kawai et al.
CANCER (2008)
A Near-Infrared Cell Tracker Reagent for Multiscopic In Vivo Imaging and Quantification of Leukocyte Immune Responses
Filip K. Swirski et al.
PLOS ONE (2007)
Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer
E Sato et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Share Paper
